Saturday 3 October 2015

25 million dollar capital raising

are these guys for real?

the distributors' deal allow them to sell those shares anyway they want - including on market!!! The fact they are using these guys and these methods would suggest that they may have burnt their bridges with hedge funds and reputable brokers.

this is the opposite of an on market share buyback. Like a giant put option placed by the company on its own shares.

It might be some kind of bizarre insurance policy to cover their salaries in the event any, or all, of their trials flop. What is an extra 25 million meant to do otherwise? So, rather than those trials producing some much needed upward price tension, we will have no share price rise into those top line reports due to the dilution and the fact that the distributors will sell into any strength for their 3% commission.

Raising cash into this weakened market for BOTA is a complete joke, and especially when they have spent a year boasting of their healthy cash balance.

sadly, i think they have completely crossed the line into penny dreadful territory.

I cannot believe the major shareholders are allowing this.

I wish someone would take them over.






Thursday 1 October 2015

cash burn doesn't hurt everyone

Biota Pharmaceuticals, Inc. releases salary data. CEO sees compensation rise 110%


Biota Pharmaceuticals, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 1,479,427.The table is included below:
Name and Principal Position
Year
Salary
($)
Bonus
($)
Stock
Awards
($)
(1)
Option
Awards
($)
(1)
All Other
Compensation
($)
Total
($)
Joseph M. Patti (3)
2015
477,000 431,250 797,098 32,829 (4) 1,479,427
President, Chief Executive Officer and Director
2014
408,000 120,156 149,375 25,995 (4) 703,526
2013
255,385 37,500 291,660 853,596 17,244 (4) 1,455,385
Russell H. Plumb (2)
2015
318,750 172,500 98,000 30,080 (5) 878,080
Executive Chairman and Director
2014
525,000 192,250 239,000 28,256 (5) 984,506
2013
335,192 60,000 583,321 1,365,753 19,431 (5) 2,363,697
The above information was disclosed in a filing to the SEC.